Jason M. Hafron, MD

Michigan Institute of Urology/Solaris Health

St. Clair Shores, Michigan

Dr. Hafron is the Chief Medical Officer and Medical Director of Clinical Research at Michigan Institute of Urology. He is a professor of urology at the William Beaumont School of Medicine, Oakland University in Royal Oak, and is experienced in all areas of adult urology.

Dr. Hafron received his Bachelor of Science degree from the University of Michigan and his Doctor of Medicine degree from Loyola University Chicago-Stritch School of Medicine. He then completed his General Surgery and Urology Residency at Albert Einstein College of Medicine, Montefiore Medical Center in New York City, and continued his training as a Fellow in Advanced Laparoscopic and Robotic Surgery at the Cleveland Clinic Foundation, Glickman Urological and Kidney Institute.

Dr. Hafron has published numerous peer-reviewed journal articles on topics related to his expertise and has presented his work at many national and international scientific meetings. He is on the editorial board of the International Urology and Nephrology journal, Urology Times and Urologists in Cancer Care.

He previously served on the Board of Directors of the United Physicians Organization and currently serves on the Board of Directors for LUGPA.

Dr. Hafron has repeatedly been named Top Doctor for Hour Detroit Magazine, and Top Doctor by Castle and Connolly. He is the recipient of many clinical research awards.

Talks by Jason M. Hafron, MD

2025 AUA SUFU Microhematuria Guideline

Posted by Diane K. Newman, DNP, ANP-BC, FAAN, FAUNA, BCB-PMD and Jason M. Hafron, MD | Apr 2025

Jason M. Hafron, MD reviews the 2025 AUA/SUFU amendment to the microhematuria guideline.

Implementing Changes in Patient Behavior

Posted by Jason M. Hafron, MD | Jun 2024

Jason M. Hafron, MD, provides guidance on implementing changes in ADT patient behavior and motivating compliance with lifestyle adjustments. He begins by reviewing the body composition changes which result from ADT.

Dr. Hafron discusses how these changes in body composition, along with other adverse effects of ADT, led to the creation of the Prostate Cancer 360 (PC36) Working Group. This interdisciplinary group developed monitoring and management recommendations intended to mitigate or prevent ADT-associated adverse events in a PC360 Handbook, which includes pre-ADT counseling on lifestyle changes.

He presents the benefits of different levels of physical exercise for patients on ADT. He examines data demonstrating the impact of standardized exercise on ADT patient QoL, noting that physical exercise has significant benefits.

Dr. Hafron concludes with guidance on patient nutrition. He notes that diet has a significant influence on prostate cancer survival rate, with a typical Western diet significantly increasing the mortality rate for patients on ADT.

What Makes Millennials Tick? Understanding the Young Urologist

Posted by Jason M. Hafron, MD | Jun 2019

Jason M. Hafron, MD, discusses the growing presence of millennials in the workplace, particularly in urologic practices. He emphasizes that millennial physicians’ have the ability to advance the urologic field by applying their talents and perspectives regarding technology, efficiency, and physician/patient relationships.